You can narrow down the results using the filters
-
An Open Label Study of Alcohol Withdrawal Syndrome in the Outpatient Setting Using Vigabatrin
Expand descriptionAn open-label trial to investigate the use of vigabatrin to manage alcohol withdrawal in an outpatient setting. Participants will receive vigabatrin 2gm daily for four days, with regular assessments of withdrawal severity and benzodiazepine use. Follow-up will occur at 30 days post cessation of trial medication. We hypothesize that treatment of alcohol withdrawal with vigabatrin in a community setting is safe and tolerable.and will result in an overall use of diazepam of less than 100mg.
-
Biomechanical effects of 3D-printed metamaterial foot orthoses with anti-pronatory graded stiffness on lower limb kinematics and kinetics in healthy adults: A within subjects immediate effects cross over study
Expand descriptionExcessive or prolonged foot pronation has been associated with increased mechanical loading of the lower limb and is associated with overuse injuries. Foot orthoses are commonly used to redistribute plantar pressures and modify lower-limb biomechanics, with anti-pronatory design features intended to reduce injurious loads associated with pronation by increasing medial ground reaction forces. However, conventional foot orthoses often produce inconsistent biomechanical outcomes, The research team has developed an approach to produce accessible and low-cost 3D-printed metamaterial foot orthoses with regionally graded stiffness that can precisely control mechanical properties across the device. These orthoses have the potential to provide more targeted anti-pronatory effects than conventional orthoses by selectively increasing medial stiffness while reducing material waste through additive manufacturing. This within-subjects randomised crossover study in healthy adults will compare the immediate biomechanical effects of 3D-printed metamaterial foot orthoses incorporating anti-pronatory graded stiffness with conventional prefabricated anti-pronatory and neutral foot orthoses. Primary outcomes will include plantar pressure distribution and lower-limb kinetics and kinematics during walking. The results of this study will provide insight into the biomechanical effects of graded metamaterial orthoses and inform larger clinical studies evaluating their effectiveness in people with pronation-related musculoskeletal conditions.
-
The impact of motivational interviewing or dialectical behaviour therapy pre-commitment on motivation to engage in therapy for suicidal youth prior to admission to a youth mental health subacute unit.
Expand descriptionThis study investigates whether adding a brief, single-session intervention before admission can improve outcomes for young people aged 16 to 21 entering a sub-acute mental health service. Participants will receive a pre-admission session based on either Motivational Interviewing (MI) or Dialectical Behaviour Therapy Pre-Commitment (DBT-PC), and their outcomes will be compared with those receiving treatment as usual. The study will examine whether these interventions increase motivation to engage in therapy, as well as actual engagement during admission, measured through attendance at group and individual sessions and completion of homework. It will also assess whether the interventions lead to better clinical outcomes, including reduced suicide risk, increased psychological growth, and fewer hospital bed days or emergency department presentations at discharge and follow-up. Finally, the study will explore how motivation and engagement interact to influence the relationship between pre-admission symptoms and discharge outcomes, helping to clarify the role engagement plays in young people's mental health recovery.
-
Cannabidiol (CBD) for Alcohol Use Disorder (AUD) Management A Multisite, Double blind, Placebo controlled, Randomised Controlled Trial for reducing heavy drinking in adults.
Expand descriptionThis is a randomised, double-blind, placebo-controlled clinical trial designed to evaluate the efficacy of cannabidiol (CBD) compared with placebo in reducing alcohol consumption among adults with alcohol use disorder (AUD). Participants who have an Alcohol Used Disorder will be given bottles of CBD (or placebo) to take the recommended dose each day (a few drops, applied orally) for 12 weeks. Participants will attend for regular checks and drug dispensing during the treatment period. At Week 12, participants will have various checks to confirm whether drinking has reduced, again 12 weeks later an appointment will be held to check how participants have managed in the absence of the study drug .
-
Telehealth-delivered step-down for alcohol and other drug withdrawal: The step-ahead project
Expand descriptionInpatient withdrawal management provides highly supportive care to allow people to safely and successfully complete their withdrawal episode. This duration of hospitalisation is of significant burden, both at the individual level and health system level. Expert consensus from the Clinical Directors of the five Local Health Districtss involved in this project have identified a potential solution – providing the option of a step-down model of care for patients admitted to hospital for alcohol and/or drug withdrawal. Based on clinical risk assessment, this would allow for patients to complete withdrawal in the community, reducing burden on hospital beds and allowing people to receive care from their own homes with access to personal supports. This project seeks to evaluate the impact of this change on length of stay and clinical outcomes using a stepped-wedge trial design where hospitals will randomly begin offering step-down care as an option to their patients over a 54 week period.
-
Comparing Heated Humidified High Flow Nasal Cannula and Continuous Positive Airway Pressure Therapy for Children with Obstructive Sleep Apnoea
Expand descriptionThis trial compared two breathing therapies — high-flow nasal cannula (HFNC) and CPAP (the current standard treatment), to see whether HFNC was effective as well, and also tolerated for children with moderate-to-severe obstructive sleep apnoea. We also asked children which one they found more comfortable. Each child was studied for one night while sleeping, using sensors to measure how well they were breathing and sleeping on each therapy.
-
The Momentum Course: A randomised controlled trial of a remotely-delivered health behaviour change intervention for adults with cardiovascular disease or risk and depression or anxiety symptoms
Expand descriptionThe study is testing a new internet-based health program that can be done from home. The aim is to find out if it helps improve important healthy actions (such as diet and exercise), as well as emotional wellbeing, in adults who have heart or blood vessel conditions or are at risk for these, and who also have symptoms of depression or anxiety. The program is psychologically-informed and designed to teach skills for setting goals, maintaining healthy actions in the long term, and overcoming common challenges.
-
Hypothermic Oxygenated Perfusion (HOPE) in Donation after Circulatory Death (DCD) for Adult Heart Transplantation Patients
Expand descriptionThe shortage of donors in heart transplantation remains a global issue. Recently, there has been significant advancement in the field of organ preservation including our recent study using hypothermic oxygenated perfusion (HOPE) in donation after brain death (DBD) donor hearts and clinical experience in heart transplantation using donation after cardiac death (DCD) donor hearts. We hypothesize that combining these methods will provide comparable outcomes to current techniques whilst increasing the number of heart donors to address the shortage of donor organs.
-
HeartPath+: A single site effectiveness/implementation feasibility study to test the co-designed HeartPath+ website for patients with coronary heart disease
Expand descriptionHeartPath+ is a digital educational resource for individuals who have experienced a coronary heart event. The early stages of transition from leaving hospital to coming home is a crucial time where many have felt uncertain and lacked information and support to manage their heart health and transition through to outpatient programs such as cardiac rehabilitation. HeartPath+ has been designed with lived experienced consumers. The aim is to empower and assist Australian living with heart disease and their family to actively manage their heart health.
-
Can the use continuous glucose monitors in a Diabetes Multidisciplinary Team High Risk Foot Clinic improve patient related outcomes - A feasibility study.
Expand description